Acute Myeloid Leukaemia (AML) is frequently associated to normal karyotype and DNMT3A mutations (R882). Since we previously demonstrated distinctive miRNA expression in some AML groups, we study 384 miRNA in 9 selected DNMT3A-mutated NK-AML patients. Comparing these data with our previous results obtained in 31 DNMT3A-unmutated AML, we focused on a significant up-regulation of miR-155, miR-29a, miR-196b and miR-25. We investigated expression of these miRNAs in additional 24 DNMT3A-mutated AML patients and we confirm the up-regulation of miR-155, miR-29a and miR-196b; in particular, we judged very interesting the over expression of miR-29a since is known to directly target DNMT3A, TET1 and TDG mRNAs. Evaluating the expression levels of these targets in 17 AML DNMT3A-mutated patients, we revealed a no significant differences in expression of DNMT3A and TDG but a significant down-regulation of TET1. These data suggest that miR-29a acts as DNA methylation-regulator: in presence of DNMT3A activating mutations and TET1 down-regulation it may probably cause a perturbation of DNA methylation. In fact, analyzing the methylation of the bone marrow genomic DNA from 3 DNMT3A-mutated and 3 DNMT3A-unmutated cases by Methylation Sensitive Arbitrarily Primed-PCR, we found a genomic hypermethylation of DNMT3A-mutated cells compared to the unmutated ones. How DNMT3A mutations contribute to leukemogenesis is not yet well characterized. Uncovering how DNMT3A mutations affect DNA methylation and epigenetic regulation of gene expression may have important implications in treatment selection because DNA hypomethylating agents are increasingly used in AML therapies, and response to these drugs may be affected by DNMT3A changed function.
|Titolo:||Upregulation of miR-29a and genomic DNA hypermethylation in normal karyotype AML showing DNMT3A mutation|
LA ROSA, CHIARA [Membro del Collaboration Group]
CARADONNA, Fabio [Supervision]
|Data di pubblicazione:||2015|
|Citazione:||Randazzo V, Agueli C, Salemi D, Valenti D, Mirto M, Marfia A, et al. (2015). Upregulation of miR-29a and genomic DNA hypermethylation in normal karyotype AML showing DNMT3A mutation. In Proceedings of 3rd International Conference On Integrative Biology August 04-06, 2015 Valencia, Spain. OMICS International..|
|Appare nelle tipologie:||2.08 Abstract in atti di convegno pubblicato in volume|